Cargando…

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation

Oral treprostinil was recently labeled for treatment of pulmonary arterial hypertension. Similar to the period immediately after parenteral treprostinil was approved, there is a significant knowledge gap for practicing physicians who might prescribe oral treprostinil. Despite its oral route of deliv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahaghi, Franck F., Feldman, Jeremy P., Allen, Roblee P., Tapson, Victor, Safdar, Zeenat, Balasubramanian, Vijay P., Shapiro, Shelley, Mathier, Michael A., Elwing, Jean M., Chakinala, Murali M., White, R. James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448528/ https://www.ncbi.nlm.nih.gov/pubmed/28680576 http://dx.doi.org/10.1086/690109

Ejemplares similares

Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat
por: Rahaghi, Franck F., et al.
Publicado: (2022)

Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
por: Kingrey, John F., et al.
Publicado: (2023)

Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document
por: Rahaghi, Franck F., et al.
Publicado: (2017)

Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
por: Balasubramanian, Vijay P., et al.
Publicado: (2022)

Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
por: Nathan, Steven D., et al.
Publicado: (2021)

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
por: Bourge, Robert C, et al.
Publicado: (2013)

Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics
por: White, R. James, et al.
Publicado: (2020)

Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension
por: Oriaku, Ifeoma, et al.
Publicado: (2020)

Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study
por: Rahaghi, Franck F., et al.
Publicado: (2020)

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
por: Rahaghi, Franck F., et al.
Publicado: (2020)

The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
por: Bajwa, Abubakr A., et al.
Publicado: (2017)

The Rapid Initiation, Titration, and Transition from Intravenous to Oral Treprostinil in a Patient with Severe Pulmonary Arterial Hypertension
por: Gleason, James Benjamin, et al.
Publicado: (2015)

Dosing characteristics of oral treprostinil in real-world clinical practice
por: Balasubramanian, Vijay P., et al.
Publicado: (2018)

Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2013)

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
por: Rahaghi, Franck, et al.
Publicado: (2021)

Reducing rates of readmission and development of an outpatient management plan in pulmonary hypertension: lessons from congestive heart failure management
por: Dolan, Justin, et al.
Publicado: (2020)

Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension study
por: Feldman, Jeremy P., et al.
Publicado: (2021)

Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
por: Chapman, Richard W., et al.
Publicado: (2021)

An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum
por: Burton, James O., et al.
Publicado: (2022)

Implantable system for treprostinil: a real-world patient experience study
por: Shapiro, Shelley, et al.
Publicado: (2020)

Recommendations for effective documentation in regional anesthesia: an expert panel Delphi consensus project
por: Ahmed, Hassan M, et al.
Publicado: (2022)

Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension
por: Coons, James C., et al.
Publicado: (2017)

Treprostinil for pulmonary hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2008)

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
por: Waxman, Aaron, et al.
Publicado: (2023)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
por: Hill, Nicholas S., et al.
Publicado: (2022)

Management of paraesophageal hiatus hernia: recommendations following a European expert Delphi consensus
por: Gerdes, Stephan, et al.
Publicado: (2023)

Improving the Quality of Life of Cancer Survivors in School: Consensus Recommendations Using a Delphi Study
por: Galán, Santiago, et al.
Publicado: (2021)

International Consensus Recommendation Guidelines for Subcutaneous Infusions of Hydration and Medication in Adults: An e-Delphi Consensus Study
por: Broadhurst, Daphne, et al.
Publicado: (2023)

Inhaled treprostinil: a therapeutic review
por: Channick, Richard N, et al.
Publicado: (2012)

Inhaled treprostinil and pulmonary arterial hypertension
por: Nadler, Samuel T, et al.
Publicado: (2010)

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
por: Rahaghi, Franck F., et al.
Publicado: (2022)

Breast Implant Selection: Consensus Recommendations Using a Modified Delphi Method
por: Magnusson, Mark R., et al.
Publicado: (2019)

Effective treatment of malignant atrophic papulosis (Köhlmeier-Degos disease) with treprostinil – early experience
por: Shapiro, Lee S, et al.
Publicado: (2013)

Treprostinil stimulates the engraftment of haematopoetic stem cells
por: Hussain, Filza, et al.
Publicado: (2011)

Successful management of an inadvertent excessive treprostinil overdose
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2013)

Delphi Study Consensus Recommendations: Patient Selection and Preoperative Planning Measurements for Natrelle 410
por: Hedén, Per, et al.
Publicado: (2015)

Delphi Consensus Recommendations: Intraoperative Technique and Postoperative Management of Patients with Natrelle 410 Implants
por: Maxwell, G. Patrick, et al.
Publicado: (2015)

Treatment Recommendations for Phantom Limb Pain in People with Amputations: An Expert Consensus Delphi Study
por: Limakatso, Katleho, et al.
Publicado: (2021)

Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy
por: Aziz-Bose, Rahela, et al.
Publicado: (2022)

Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children: A Modified Delphi Consensus Statement
por: Goldstein, Stuart L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t94iro2k61ltoqpn1obtams2hq